Published in Lancet on April 25, 1992
Fragmentation of pulmonary embolus. Lancet (1992) 1.41
Frequency of risk factors for ischaemic heart-disease in a healthy British population. With particular reference to serum-lipoprotein levels. Lancet (1974) 8.19
The sodium-potassium hypothesis as the basis of electrical activity in frog ventricle. J Physiol (1960) 4.01
The microbiology and pathogenesis of infective endocarditis. Br Heart J (1983) 3.36
The cardiomyopathies. Br Heart J (1972) 3.14
Primary restrictive cardiomyopathy. Non-tropical endomyocardial fibrosis and hypereosinophilic heart disease. Br Heart J (1977) 2.68
Acute subvalvar mitral incompetence. Lancet (1966) 2.65
Percutaneous catheter fragmentation and distal dispersion of proximal pulmonary embolus. Lancet (1991) 2.36
Enhanced basal nitric oxide production in heart failure: another failed counter-regulatory vasodilator mechanism? Lancet (1994) 2.25
Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. Br Heart J (1985) 2.22
Mechanisms of angina pectoris in syndrome X. J Am Coll Cardiol (1991) 2.16
Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction. N Engl J Med (1994) 2.10
Six minute walking test for assessing exercise capacity in chronic heart failure. Br Med J (Clin Res Ed) (1986) 2.09
Regression of primary pulmonary hypertension. Br Heart J (1976) 2.03
Clinical features of fifteen patients with the hypereosinophilic syndrome. Q J Med (1983) 1.96
Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet (1996) 1.95
Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies. Circulation (1990) 1.91
Eosinophilia and heart disease. Br Heart J (1977) 1.90
Infective endocarditis. Br J Hosp Med (1980) 1.88
Time and displacement dependence of cardiac contractility: problems in defining the active state and force-velocity relations. Fed Proc (1966) 1.87
Antibodies to Coxsackie B viruses in congestive cardiomyopathy. Br Heart J (1979) 1.86
Echocardiography of the mitral valve in aortic valve disease. Br Heart J (1971) 1.86
Assessment of site and severity in congenital aortic stenosis. Br Heart J (1967) 1.83
Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans. Circulation (1993) 1.74
Right ventricular dilated cardiomyopathy. Br Heart J (1984) 1.74
M mode echocardiography in hypertrophic cardiomyopathy: diagnostic criteria and prediction of obstruction. Am J Cardiol (1980) 1.72
Cadiovascular complications of homozygous familial hypercholesterolaemia. Br Heart J (1980) 1.69
Diastolic function in hypertrophic cardiomyopathy: relation to exercise capacity. J Am Coll Cardiol (1992) 1.66
Active state in cardiac muscle. Physiol Rev (1968) 1.66
Effects of increased inspired oxygen concentrations on exercise performance in chronic heart failure. Lancet (1992) 1.65
Management of pregnancy in patients with hypertrophic cardiomyopathy. Br Med J (1979) 1.64
Analysis of symptomatic course and prognosis and treatment of hypertrophic obstructive cardiomyopathy. Br Heart J (1971) 1.63
Cardiovascular features of 11 patients with eosinophilic endomyocardial disease. Q J Med (1983) 1.62
The bowel, the genitourinary tract, and infective endocarditis. Br Heart J (1984) 1.62
Congenital fistula between the aorta and left atrium. Br Heart J (1987) 1.61
Natural history of secundum atrial septal defect in adults after medical or surgical treatment: a historical prospective study. Br Heart J (1994) 1.59
Infective endocarditis in three patients with hypertrophic obstructive cardiomyopathy. Br Med J (1968) 1.56
Cine angiography of left ventricular aneurysms. Clin Radiol (1972) 1.53
Beta-adrenergic blockade in hypertrophic obstructive cardiomyopathy. Br Med J (1966) 1.53
Is aspirin safe for patients with heart failure? Br Heart J (1995) 1.49
Noninvasive measurement of renal blood flow with technetium-99m-DTPA in the evaluation of patients with suspected renovascular hypertension. J Nucl Med (1990) 1.48
Mechanism of mitral regurgitation in hypertrophic obstructive cardiomyopathy. Br Heart J (1970) 1.48
Clinical definitions and classification of cardiomyopathies. Postgrad Med J (1972) 1.47
Angiographic characteristics of infarct-related and non-infarct-related stenoses in patients in whom stable angina progressed to acute myocardial infarction. Am Heart J (1998) 1.45
Magnitude of myocardial dysfunction is greater in painful than in painless myocardial ischemia: an exercise echocardiographic study. J Am Coll Cardiol (1995) 1.44
Genetic testing for familial hypertrophic cardiomyopathy in newborn infants. BMJ (1995) 1.44
Usefulness of echocardiography to differentiate dilated cardiomyopathy from coronary-induced congestive heart failure. Am J Cardiol (1991) 1.43
Pregnancy in a patient with a mitral-valve prosthesis. Lancet (1968) 1.41
Factors that influence the outcome of primary pulmonary hypertension. Br Heart J (1986) 1.41
Onset of contractility in cardiac muscle. J Physiol (1966) 1.41
The diagnostic significance of reciprocal ST segment depression in acute myocardial infarction. Q J Med (1989) 1.40
Variability of coronary blood flow reserve assessed by Doppler catheter after successful thrombolysis in patients with acute myocardial infarction. Am Heart J (1993) 1.39
Dental prophylaxis for endocarditis. Lancet (1992) 1.39
Pregnancy complicated by cardiac valvular disease and hypertension. Problems of management. Chest (1991) 1.38
Prediction of outcome in dilated cardiomyopathy. Br Heart J (1987) 1.35
Hypereosinophilic syndrome: endomyocardial fibrosis. Heart (1996) 1.34
Arrhythmia in hypertrophic cardiomyopathy: exercise and 48 hour ambulatory electrocardiographic assessment with and without beta adrenergic blocking therapy. Am J Cardiol (1980) 1.30
Management of pregnancy complicated by hypertrophic obstructive cardiomyopathy. Br Med J (1968) 1.28
Reduced alveolar-capillary membrane diffusing capacity in chronic heart failure. Its pathophysiological relevance and relationship to exercise performance. Circulation (1995) 1.27
Outcome of pregnancy in women with valve prostheses. Br Heart J (1994) 1.27
Amiodarone for long-term management of patients with hypertrophic cardiomyopathy. Am J Cardiol (1984) 1.26
Selective coronary arteriography. A review of 18 months' experience. Clin Radiol (1970) 1.25
Echocardiographic features of eosinophilic endomyocardial disease. Br Heart J (1982) 1.24
Clinical recognition of the cardiomyopathies. Circ Res (1974) 1.24
Transplantation of the heart. Am Heart J (1969) 1.23
Absence of myocardial dysfunction during stress in patients with syndrome X. J Am Coll Cardiol (1991) 1.23
Pulmonary hypertension and systemic lupus erythematosus. J Rheumatol (1986) 1.21
The effects of temperature upon contraction and ionic exchange in rabbit ventricular myocardium. Relation to control of active state. J Gen Physiol (1968) 1.21
Hydralazine in the management of left ventricular failure. Am J Cardiol (1979) 1.21
Urgent aortic-valve replacement for acute aortic regurgitation due to infective endocarditis. Lancet (1971) 1.20
Individual sarcomere length determination from isolated cardiac cells using high-resolution optical microscopy and digital image processing. Biophys J (1982) 1.17
Double-blind trial of propranolol and practolol in hypertrophic cardiomyopathy. Br Heart J (1973) 1.17
Myocardial infarction with normal coronary angiogram. Possible mechanism of smoking risk in coronary artery disease. Br Heart J (1980) 1.16
Serum lipoprotein abnormalities in patients with ischaemic heart disease: comparisons with a control population. Br Med J (1974) 1.16
Incidence, mortality and prevention of infective endocarditis. J R Coll Physicians Lond (1986) 1.15
The role of ambulatory ST-segment monitoring in the diagnosis of coronary artery disease: comparison with exercise testing and thallium scintigraphy. Eur Heart J (1987) 1.13
Contractile force measured in unskinned isolated adult rat heart fibres. Nature (1979) 1.13
Dobutamine stress echocardiography for detection and assessment of coronary artery disease. J Am Coll Cardiol (1992) 1.13
Assessment of long-term plasma exchange for familial hypercholesterolaemia. Br Heart J (1980) 1.12
Significance of abnormal electrocardiograms in highly trained athletes. Am J Cardiol (1982) 1.12
Successful surgical treatment of two patients with eosinophilic endomyocardial disease. Br Heart J (1981) 1.12
QT-interval abnormalities in hypertrophic cardiomyopathy. Clin Cardiol (1992) 1.11
Correlation of the glycoside response, the force staircase, and the action potential configuration in the neonatal rat heart. Circ Res (1975) 1.10
The functional defect in amyloid heart disease. The "stiff heart" syndrome. Am J Cardiol (1975) 1.09
Assessment of right ventricular function and anatomy using peripheral vein infusion of krypton 81m. Br J Radiol (1983) 1.08
Value of the bipolar lead CM5 in electrocardiography. Br Heart J (1986) 1.08
After the infarct. Br Med J (Clin Res Ed) (1983) 1.07
Perfusion lung scanning in obliterative pulmonary hypertension. Br Heart J (1973) 1.06
The natural history of left ventricular hypertrophy in hypertrophic cardiomyopathy: an electrocardiographic study. Circulation (1982) 1.06
Enzymic analysis of endomyocardial biopsy specimens from patients with cardiomyopathies. Br Heart J (1977) 1.06
Pulmonary valve stenosis without ventricular septal defect: results of surgery. Thorax (1966) 1.04
Pregnancy after surgical correction of tetralogy of Fallot. Br Med J (Clin Res Ed) (1982) 1.02
Long-term complications of valve replacement. Br Med J (Clin Res Ed) (1982) 1.02
Cross sectional echocardiographic assessment of the aortic root and coronary ostial stenosis in familial hypercholesterolaemia. Br Heart J (1983) 1.02
Relationship between hemostatic abnormalities and neuroendocrine activity in heart failure. Am Heart J (1994) 1.01
Aspirin to prevent growth of vegetations and cerebral emboli in infective endocarditis. J Intern Med (1992) 1.01
Marked variation in the cardiomyopathy associated with Friedreich's ataxia. Heart (1999) 1.00
Q waves and coronary arteriography in cardiomyopathy. Br Heart J (1972) 0.99